Scalable, Turn-key 3D Engineered Muscle Tissues for Drug Discovery
Time: 12:45 pm
day: Day One
- Drug discovery for muscle indications often rely on direct measurement of muscle contractility, which is hard to measure in vitro.
- We have developed a novel, label-free platform that easily fabricates and measures the contractility of complex 3D muscle tissue models.
- The platform utilizes both primary and iPSC-derived cell lines, enabling facile disease modeling across a host of indications in skeletal and cardiac muscle diseases.